Blue Horizon Corporation is an investment firm that invests in companies and businesses in the agriculture and food processing sector. The firm also partners with farmers, food producers, and distribution chains. It was founded in 2016 and headquartered in Zurich, Switzerland. Plant based, food tech,

Blue Horizon Corporation

Moira Capital Partners is private equity firm

Moira Capital Partners

Cubiq Foods

Cubiq Foods has developed a platform of cultivate fats for industrial clients. It is based on two main ingredients, Cubiq Smart OMEGA-3 and Cubiq Smart Fat.

Cubiq Foods is a Spanish startup developing novel plant-based fats. Cubiq’s portfolio includes Go!Drop fat replacer, Go!Mega3 microencapsulated Omega-3 algae oil, and Go!Great cultivated animal fat. These products claim to offer several benefits for alternative food production, including improved nutrition, lower caloric content, and better texture and mouthfeel.

Making meat sustainable over the long term

Cell-cultured Meat

Cubiq Foods develops and produces alternative fats for the food industry. The company's product portfolio includes Go!Drop, a water-oil emulsion that can replace traditional oils with an 80% reduction in oil usage while maintaining a 1:1 replacement ratio. The company also produces Smart Omega-3, a microencapsulated omega-3 product that maintains its properties without fish flavors, and Smart Fat, a vegan emulsion designed to replace animal fats in processed meat products, dairy derivatives, and saturated vegetable fats. Cubiq Foods' technology platform enables the conversion of liquid oils into solid or semi-solid fats suitable for plant-based applications. The company also develops cell-cultivated fats rich in omega-3s using proprietary production methods.

Alternative fat solutions

GrowMeat: Cultivating the Meat of the Future in Málaga, Spain

Cargill enters alternative fats partnership with Cubiq Foods

Update: Spanish Food Startup Raises €12M to Grow Healthier Animal Fats

Newtree Impact

Cubiq Foods Receives $6M in Cargill Bridge Round to Commercialize Cultivated Fat

Barcelona-based Cubiq Foods gets €5 million to bring sustainable replacement fats to market

Innovation on the menu: 10 Spanish FoodTech startups to watch in 2023 and beyond

Unlocking nature's benefits for elevated wellness

Functional Ingredients

Europe Cultured Meat Market Analysis and Forecasts, 2024-2033 with Mosa Meat, Meatable, and CUBIQ FOODS Leading the $500+ Million Industry

UOBO

To develop plant-based egg alternatives that reduce the environmental impact of egg production and provide a sustainable solution for large-scale manufacturers.

A booming food and beverage segment with a history as rich and varied as its present-day product offerings

Plant-based Dairy & Egg

Producers of plant-based egg alternatives for general consumption (used in baking and cooking) using pulses such as mung beans, peas, soy, chickpeas, etc.

Cargill

Cargill enters into partnership with Cubiq Foods to commercialise novel plant-based fats

A new wave of meat, fish, and poultry alternatives are driving this hyper-growth industry into the mainstream

Plant-based Meat

Suppliers of plant ingredients such as legumes, mycelia, and other proteins for the production of plant-based meat, fish, poultry, and pork products; suppliers of technology related to the production of plant-based meat

Cubiq Foods develops and produces alternative fats for the food industry. The company's product portfolio includes Go!Drop, a water-oil emulsion that can replace traditional oils with an 80% reduction in oil usage while maintaining a 1:1 replacement ratio. The company also produces Smart Omega-3, a microencapsulated omega-3 product that maintains its properties without fish flavors, and Smart Fat, a vegan emulsion designed to replace animal fats in processed meat products, dairy derivatives, and saturated vegetable fats. Cubiq Foods' technology platform enables the conversion of liquid oils into solid or semi-solid fats suitable for plant-based applications. The company also develops cell-cultivated fats rich in omega-3s using proprietary production methods.
Key customers and partnerships
In May 2022, Cubiq Foods established a strategic partnership with Cargill, which led to product co-development and commercial agreements in March 2023. Through this partnership, Cargill adds Cubiq's plant-based "smarter fats" to its ingredients and plant-based formulation offerings. The company has established relationships with industrial clients for its fat solutions, including Kerry Group and Tyson US.

Cubiq Foods is a Spanish startup developing novel plant-based fats. Cubiq’s portfolio includes Go!Drop fat replacer, Go!Mega3 microencapsulated Omega-3 algae oil, and Go!Great cultivated animal fat. These products claim to offer several benefits for alternative food production, including improved nutrition, lower caloric content, and better texture and mouthfeel.Key partnerships and customersIn <a href="https://sp-edge.com/updates/16793">March 2023</a>, the company partnered with Cargill to co-develop and commercialize Cubiq Foods' plant-based fats. The partnership was expected to include the large-scale development of Cubiq Foods' Go!Drop.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/10319">May 2022</a>, Cubiq Foods raised EUR 5.75 million (~USD 6 million) from a consortium of investors, including Moira Capital Partners, SGEIC, Newtree Impact, and Cargill.

Mosa Meat is a Dutch cell-cultured meat startup founded by Dr. Mark Post of Maastricht University, and was the first-ever company to produce a lab-grown meat burger. The startup produces meat by growing myosatellite cells (muscle stem cells) extracted from an animal in a bioreactor fed with a nutrient-dense medium.The company replaced the fetal bovine serum (FBS) from its growth medium in July 2020, which led to an 88x cost reduction in its medium. As of March 2024, Mosa Meat operated the Center for Advanced Meat Production, Upscaling, and Sustainability (CAMPUS), a facility spanning over 79,000 sq ft that was designed to be expandable as demand grows.In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide. In <a href="https://sp-edge.com/updates/21645">September 2023</a>, Mosa Meat became the first cultivated meat company to attain B Corp certification. The company also announced plans to apply for regulatory approval in countries worldwide. In <a href="https://sp-edge.com/updates/31970">July 2024</a>, it conducted the first official tasting of its cultivated beef product, the Mosa Burger, in the Netherlands. This event gathered Dutch cattle farmers, food product developers, and industry representatives to collect expert feedback.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/14175">November 2022</a>, Mosa Meat entered into an agreement with Singapore-based contract development and manufacturing organization (CDMO) Esco Aster to commercialize its cultivated beef in Singapore. Further, in <a href="https://sp-edge.com/updates/16845">March 2023</a>, the company partnered withNutreco to develop a cell feed supply chain that can expedite production and scalability while reducing cost.Funding and financialsIn its latest funding round in <a href="https://sp-edge.com/updates/28536">April 2024</a>, the company raised EUR 40 million (~USD 42.5 million) in an oversubscribed funding round co-led by Lowercarbon Capital and M Ventures, with participation from PHW Group, Invest-NL, LIOF, and LEF. The funds were earmarked for scaling production procedures, reducing production costs, and gearing up for commercialization.

Mosa Meat

SuperMeat is a cellular agriculture startup developing cultured chicken meat. The company uses chicken cells and claims to grow them in a culture medium free from antibiotics and contaminants to develop its products. SuperMeat also operates a test kitchen known as The Chicken. It is claimed to be the world’s first farm-to-fork facility where diners can observe the production of cultivated chicken.In <a href="https://sp-edge.com/updates/21733">September 2023</a>, The Orthodox Union (OU) certified SuperMeat’s cultivated chicken as “kosher.” Further, the OU and SuperMeat will collaborate on establishing guidelines for the industry.In&nbsp;<a href="https://sp-edge.com/updates/35765">November 2024</a>, the company announced it had achieved cost parity for its cultivated chicken and could produce it at at USD 11.79 per pound at scale, matching the price of premium US pasture-raised chicken.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/9319">March 2022</a>, SuperMeat signed an MoU with PHW to supply cultivated meat products including chicken, turkey, and duck to the European market. The company also <a href="https://sp-edge.com/updates/8997">partnered</a> with Ajinomoto to set up a joint venture to accelerate the commercialization of cultivated meat while focusing on developing a cost-competitive cell growth media.In <a href="https://sp-edge.com/updates/11867">July 2022</a>, the company signed an MoU with Switzerland’s largest retail supermarket chain and leading meat manufacturer, Migros to expedite production and distribution of cultured meat at a commercial scale with a focus on European markets.&nbsp;

SuperMeat

Uncommon (formerly HigherSteaks) is a UK-based cell-cultured meat startup that uses cellular agriculture to grow pork from animal cells. The company leverages cellular agriculture and in-house developed RNA technologies to cultivate meat and claims its technology eliminates the need for genetic engineering and growth media.In July 2020, the company unveiled the world's first lab-grown pork belly prototype and the second cell-based bacon (behind Mission Barns cell-based bacon unveiled in early 2020). The pork belly and the bacon were produced from a combination of cell-cultured muscle and plant-based proteins and fat. Uncommon plans to commercialize its cell-cultured meat by 2022-2025, pending regulatory approval.Funding and financialsIn <a href="https://sp-edge.com/updates/19267">June 2023</a>, the company raised USD 30 million in Series A funding co-led by Balderton Capital and Lower Carbon Capital, with participation from Redalpine, East Alpha, and others. The funds were earmarked for the development of its innovative approach, expanding production, increasing the team, and initiating regulatory approvals.

Uncommon

Multus, a spin-off of SOSV’s IndieBio program, is a biotechnology company that specializes in the development of growth media solutions for cellular agriculture applications. Its portfolio includes serum-free FBS alternatives (Proliferum M and Proliferum LSR) and solutions that support cell adhesion (rh-Vitronectin) during the cultivation process.Multus leverages MediOp, a growth media formulation design platform, to develop its solutions. According to the company, this technology allows optimizing solutions using automated data analysis and insights. Multus also uses this platform to provide contract manufacturing services for custom formulation design and food-safe manufacturing compliant with ISO22000 to customers in North America, Europe, and Asia-Pacific.In <a href="https://sp-edge.com/updates/25572">January 2024</a>, the company unveiled what it claims to be the first large-scale production plant making serum-free growth media in the cultivated meat industry.Key customers and partnershipsIn <a href="https://sp-edge.com/updates/24911">December 2023</a>, the company partnered with New Wave Biotech, a bioprocess optimization software company, under a project funded through an Innovate UK Engineering Biology grant. Through this partnership, Multus planned to use New Wave Biotech’s AI software to optimize its process of developing precision-fermented ingredients for cell cultivation.Funding and financialsIn <a href="https://sp-edge.com/updates/15702">January 2023</a>, the company raised GBP 7.9 million (~USD 9.6 million) in a funding round led by Mandi Ventures with participation from SOSV, Big Idea Ventures, and others. The funding from this round was earmarked for the development of its animal-free growth media production facility in London.

Multus

Based in Israel, Believer Meats (Future Meat Technologies prior to November 2022) develops hardware and cell lines for the manufacturing of cell-cultured meat, to commercialize its manufacturing hardware and techniques.Believer Meats uses fibroblast cells that can be triggered with small molecules to develop either fat or muscle cells. Fat and muscle cells are cultured in a unique bioreactor that removes the waste material from the media, allowing the company to recycle parts of the media to reduce feed media input by as much as 50%. The startup replaced FBS with molecules derived from Chinese hamster ovaries (CHO) to reduce production costs and plans to achieve price parity with animal counterparts.In <a href="https://sp-edge.com/updates/12623">August 2022</a>, the company announced it has developed what it claims to be the world’s first cultivated lamb, using cell lines isolated from Awassi sheep.In <a href="https://sp-edge.com/updates/15195">December 2022</a>, the company announced it has begun development of a 200,000 sq foot production facility in Wilson, North Carolina with an annual capacity of ~22 million lbs, which is claimed to be the largest cultivation facility in the world. Believer Meats plans to produce cultured chicken, pork, beef, and lamb for US, European, and Asian markets.Key customers and partnershipsIn March 2022, the company <a href="https://sp-edge.com/updates/9320">partnered</a> with Charoen Pokphand Foods to develop cultivated meat products for Asia.In <a href="https://sp-edge.com/updates/17710">April 2023</a>, Believer Meats signed an MoU with Archer Daniels Midland (ADM) to collaborate on the development and commercialization of cultivated meat products. Further, ADM will offer its ingredient pantry and nutrition knowledge to enhance Believer's cell-cultivated meat process.In <a href="https://sp-edge.com/updates/30520">June 2024,</a> Believer Meats partnered with Abu Dhabi’s AgriFood Growth &amp; Water Abundance (AGWA), to advance cultivated meat production in the MENA region.Funding and financialsIn its <a href="https://sp-edge.com/updates/9252">latest funding round</a> in December 2021, the company raised USD 347 million in Series B funding, recording the largest investment in cell-cultured meat at the time. The round was co-led by ADM Ventures, while funds were to be used to accelerate its production plans in the US.

Believer Meats

Producers of cell-cultured seafood using cells extracted from fish. Startups have succeeded in developing prototypes of yellowtail and salmon

Producers of cell-cultured pork using cells extracted from animals. Startups have succeeded in developing prototypes of bacon and pork belly using cultured muscle and plant-based proteins and fat

Producers of cell-cultured beef using cells extracted from animals. Some producers in the industry are developing premium beef ranges such as Wagyu. Startups have only succeeded in developing prototypes in the minced form, with a few creating prototypes of (pieces of) steak using 3D bioprinters

Producers of cell-cultured chicken and duck using cells extracted from animals. Some producers in the industry are developing rare delicacies such as foie gras. Startups have only succeeded in developing products in the nugget form

Producers of growth media for cell-cultured meat production and ingredients for meat and meat analog (cell-cultured, plant-based) producers, which can include cell culture meat paste, culture fat, etc. Producers of growth media mainly focus on developing alternative growth media to FBS using plant-based or other sources

Developers of bioreactors and other technologies used in cell-cultured meat production. Industrial scaling and efficiency gains are key areas of interest for startups in the industry

Provide sustainable solutions for animal slaughter through the use of biotechnology

Certified Nutraceuticals specializes in developing bio-active ingredients for foods, beverages, and supplements. The company holds 16 US patents for ingredients and extraction processes related to pomegranate, olive leaf, grapevine extracts, and jellyfish collagen. The company pioneered the introduction of Collagen Types I, II, and III as nutritional supplements and developed three collagen ingredients: KollaGen II-xs, kollaGen I.V.X.HEM, and TendoGuard Joint and Tendon Support, which contains collagen types I, II, V, and X. In 2001, the company patented a unique method to extract collagen from chicken sternums, used in products for joint pain relief and mobility restoration. Their ingredients support healthy aging, joint health, brain health, and cognitive function. The company's manufacturing processes comply with Fair Trade criteria, eco and dietary regulations, FDA guidelines, and Kosher and Halal requirements. All products undergo analysis in accordance with the Federal Drug Administration and Cosmetics Act and the Fair Packaging and Labelling Act. The company provides comprehensive services from initial product development to manufacturing, filling, and product launch, including logistics and disposition.
Key customers and partnerships
The company maintains an international network of distributors, wholesalers, and manufacturing partners. Among these partnerships is a collaboration with Nutraceuticals Agriceuticals Technology Company (NATCO), a leading supplier of organic monk fruit and persimmons, which operates farms and factories in Guilin, China.

Certified Nutraceuticals

Nupromic is a biotechnology company that specializes in developing functional ingredients and next-generation nutraceutical products for the food industry. The company operates Mexico's first Beta Glucan production facility and manufactures differentiated ingredients used in fortified food production.

Nupromic

Beneo is a manufacturer of functional ingredients derived from natural sources including chicory root, sugar beet, rice, and wheat for food, feed, and pharmaceutical products. The company specializes in producing functional carbohydrates, fibers, and proteins that improve nutritional and technical properties of various products. Its portfolio includes Isomalt and Palatinose (sugar beet-derived carbohydrates), Orafti Inulin and Oligofructose (chicory root fibers), and wheat and rice proteins. These ingredients are used across multiple applications including dairy, confectionery, bakery, cereals, baby food, and beverages to enhance taste, texture, and nutritional benefits. In May 2022, Beneo acquired Meatless B.V., a Dutch supplier of textured plant-based ingredients, expanding its capabilities in meat and fish alternatives. The company has six production facilities located in Belgium, Chile, Germany, Italy, and the Netherlands. Beneo invested EUR 7.7 million in March 2022 to quadruple storage capacity at its Offstein, Germany facility with a new automated warehouse capable of storing over 8,500 pallets. In 2022, the company also announced a EUR 50 million investment in a new fava bean processing plant in Offstein to produce protein concentrates, starch-rich flour, and hulls, scheduled for completion in late 2024.

Beneo

AlgaeCytes is a biotechnology company specializing in the cultivation of algae to produce health and wellness ingredients. The company utilizes an advanced photobioreactor system for algae cultivation, featuring enclosed glass tubing and LED lighting to stimulate photosynthesis. AlgaeCytes' patented process optimizes the photosynthetic process, allowing microalgae to flourish and produce valuable compounds. The system regulates light, nutrient supply, and temperature, enabling efficient and consistent production year-round, regardless of external weather conditions.
The company's primary focus is on producing omega-3 oils from microalgae as an alternative to fish-derived sources. This approach offers several advantages, including suitability for vegetarian diets, reduced pressure on fish stocks, and the ability to avoid potential contamination with trace heavy metals sometimes found in fish oil supplements. AlgaeCytes' method allows for the production of high-quality omega-3 oils with variable EPA:DHA ratios, catering to different formulation requirements.
In February 2018, AlgaeCytes joined the ProFlow consortium, which secured an Innovate UK grant of nearly GBP 630,000 for a two-year development program. The consortium aims to scale up a novel acoustic cell harvesting technology developed by LabXero, which could significantly reduce the costs associated with separating algal biomass from its culture medium. This technology uses resonant sound waves to create an acoustic barrier, separating water from microalgae without the need for energy-intensive centrifugation techniques. The development of this technology could potentially lower downstream processing costs, which constitute a substantial portion of total processing expenses in algae-based omega-3 production.

AlgaeCytes

Seed Health is a microbiome science company founded in 2015 by Ara Katz and Raja Dhir. The company focuses on developing probiotics and living medicines to impact both human and planetary health. Seed Health's flagship product is DS-01, a daily synbiotic (probiotic + prebiotic) supplement formulated with 24 clinically studied bacterial strains targeting digestive, cardiovascular, dermatological, and immune health. In May 2024, the company launched vs.-01, a vaginal synbiotic clinically validated to establish an optimal vaginal microbiome dominated by Lactobacillus crispatus.
Seed Health utilizes a full-stack platform that encompasses discovery, product development, and clinical research. The company employs bioinformatics and computational analyses to interrogate the role of the microbiome in overall health and design targeted probiotics. In April 2024, Seed Health introduced CODA, a computational biology platform powered by the Human Phenotype Project, which integrates over three million phenotypic data points from more than 13,000 individuals. This platform aims to develop next-generation precision probiotics and microbiome-directed interventions for areas including metabolic health, brain health, menopause, and longevity.
The company's research extends beyond human health to environmental applications through its SeedLabs division. This includes developing probiotics for honeybees to enhance their resilience against climate change-related stressors, as well as exploring microbial solutions for plastic degradation and soil health. Seed Health collaborates with leading scientists and research institutions to advance its work across various health domains, including vaginal health, skin health, oral hygiene, pediatrics, mental health, and nutrition.
Key customers and partnerships
The company has established partnerships with several academic and research institutions to further its scientific endeavors. In 2023, Seed Health announced a collaboration with the Swiss Institute of Allergy and Asthma Research (SIAF) to develop non-toxic, microbiome-safe home and personal care products. The company also partnered with Axial Therapeutics in 2022 to launch a Gut-Brain Development Program, focusing on translating research from Caltech into probiotic innovations for neuropsychiatric health.

Seed Health

Live beneficial microorganisms and non-digestible fibers to promote a balanced gut microbiome and improve digestive health

Plant-based extracts, fibers, and herbal ingredients with health-promoting properties like anti-inflammatory, adaptogenic, and antioxidant effects

Essential fatty acids and structured lipids such as omega-3 and amino acids that support heart health, cognitive function, and energy metabolism

Small protein fragments with targeted biological activities, such as boosting immunity, improving cardiovascular health, and reducing inflammation

Essential micronutrients and compounds that support improved immune system function, bone health, hair, and skin, among others

ANALYST_QUICK_TAKE

PROMINENT_CATEGORY

<div>
 UOBO, a food tech startup from Barcelona that works on egg alternatives, has received funding of EUR 500,000, approximately USD 548,000, in a seed funding round led by Enzo Ventures.
 They will utilize these funds to create new products and expand their operations. 
 In addition, UOBO has teamed up with Cubiq Foods to develop an egg-free product for B2B customers. The goal is to help manufacturers substitute eggs in their recipes. This partnership is also expected to contribute to UOBO's objective of lessening the environmental impact of egg production.
</div> Analyst QuickTake: 
 UOBO first launched its liquid plant-based eggs for food service, made with canola and potato protein, in <a href="https: 
//sp-edge.com/updates/26160"> January 2024 </a> . The product was designed to replace eggs in various dishes, such as omelets, pastries, and custards, while claiming to offer an authentic taste.

Cubiq Foods

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless